Board of Directors


Dr. Arun Menawat, Chairman of the Board

Dr. Arun Menawat has an accomplished history of executive leadership success in the healthcare industry. Dr. Menawat served as the President & CEO and Chairman of the Board of Novadaq Technologies Inc. from April 2003 to July 2016, where he led the company from a start-up to among the top ten fastest growing medical device companies. Dr. Menawat led the company to an IPO in the Canadian TSX and US NASDAQ listing.

Prof. Amir Geva, DSc.
Founder and Chief Technology Officer

Amir founded elminda in 2006 following over 30 years of brain related research conducted as part of his academic and enterpreneurial career. Amir is a professor and the head of the Biomedical Laboratory of the Electrical, & Computer Engineering department at the Ben Gurion University of the Negev (BGU) (1994-present). Amir is an experienced entrepreneur with a significant managerial track record. In 2000 Amir founded Widemed (publicly traded on Tel Aviv Stock Exchange: TAS) and served as the company’s CEO and President until 2005. Amir is an accomplished scientist, with years of brain and EEG research and experience starting in the reserch unit of the Israeli Navy (1981-1986), the Technion Institute of Technology (1987-1994), and BGU (1994-Present) with extesive accademic research.

Ronen Gadot
Chief Executive Officer

In 2006, Ronen joined the elminda founders as a first investor and board member, recognizing the vision that brain mapping can make a significant difference for the diagnosis and treatment of brain related disorders. Before joining elminda, Ronen held executive positions for several international companies. These include Applied Materials, a Silicon Valley based Fortune 500 Company; Philips Electronics, a leading player in consumer electronics, medical imaging and monitoring equipment; and SHL Telemedicine, a pioneering company in the area of telemedicine solutions and remote care. Prior to Ronen’s career in business, he served eight-years as an F-16 fighter pilot and also flew on the Israeli Aerobatic Team.

James Zhang

Mr. James Zhang joined Shanda Capital in 2013 as Executive Director. Shanda Capital is an investment group investing in technology, media and telecommunications businesses. Mr. Zhang has 12 years’ experience in management consulting, investment and industry experience for High-tech, Telecom, Internet, Entertainment, Financial Services, Fintech, Internet Finance, Retail / e-Commerce (B2C), Consumer Goods industries.
He is Experienced in corporate strategy, BU strategy, M&A, due diligence, marketing and distribution strategy, product development strategy, supply chain management and organization restructuring.

Paul A. Mieyal, Ph.D., CFA

Paul A. Mieyal, Ph.D., CFA joined Wexford in 2006, and serves as Vice President, Director of Life Sciences Investments. Mr. Mieyal is responsible for sourcing, due diligence, negotiation, and management of $150 million of capital invested in public and private biotech and medical device companies. Mr. Mieyal is a director representative on public and private company boards, including audit and compensation committees.

Fred Cohen

Extensive sales & marketing career with successful,  creative, out of the box thinking and leadership through team building. Experience includes NHL, MISL and Auto racing. Fred also served as the Chairman of Maccabbi US Sports Team.

Back to top